Pfizer's Path to Growth: Is It Time to Buy?
Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's expectations for both earnings and revenue. One of their drugs, Lorbrena...